Sort
78,016 grants matching “breast cancer”
Re-activation of maspin tumor suppressor gene by designed transcription factors
$540,890Pilar Blancafort · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA
Studies of Materials with Physiological Properties
$540,881Stuart L Schreiber · Broad Institute, Inc. · R01 · FY2014 · GM
Studies of Materials with Physiological Properties
$540,880Stuart L Schreiber · Broad Institute, Inc. · R01 · FY2015 · GM
Flexible NLP toolkit for automatic curation of outcomes for breast cancer patients
$540,872Imon Banerjee · Mayo Clinic Arizona · U01 · FY2023 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$540,860Albert Folch · University Of Washington · R01 · FY2021 · CA
Colon cancer disparity elimination: a faith-based participatory partnership
$540,858John R. Ureda · South Carolina Hiv Council · R24 · FY2009 · MD
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$540,823Efstathios Karathanasis · Case Western Reserve University · R01 · FY2025 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$540,818Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2024 · CA
Commonly Used Medications and Risk of Colorectal Cancer Recurrence
$540,796Jessica Chubak · Kaiser Foundation Health Plan Of Washington · R01 · FY2015 · CA
DEVELOPMENTAL FUNDS (Core 002)
$540,774Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA
USING SPHINGOLIPIDS TO TARGET METABOLISM AND METASTASIS IN BREAST CANCER
$540,750University Of California Irvine · · FY2015 · Department of Defense
Statistical Methods for Genetic Epidemiology
$540,730Stanford University · R01 · FY2004 · CA
CASE CONTROL SURVEILLANCE OF SERIOUS ILLNESSES AND DRUGS
$540,693Boston University Medical Campus · R01 · FY2000 · CA
Discrete Frequency Infrared Spectroscopic Imaging for Breast Histopathology
$540,656Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2024 · EB
Kalamazoo Community Clinical Oncology Program
$540,631Raymond S Lord · West Michigan Cancer Center · U10 · FY2009 · CA
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
$540,560Kit S Lam · University Of California At Davis · R01 · FY2024 · CA
Multiparameter single-cell genomics platform for personalized treatment of cancer
$540,518Eric Brouzes · State University New York Stony Brook · R01 · FY2015 · CA
Planning and Evaluation Core
$540,515Harold I Saavedra · Ponce School Of Medicine · U54 · FY2021 · CA
Development of a Bioengineered Therapeutic Device for the Prevention of Lymphedema
$540,476Ngan F. Huang · Palo Alto Veterans Instit For Research · R01 · FY2025 · CA
PAG is a novel target in immunotherapy
$540,458Adam Mor · Columbia University Health Sciences · R01 · FY2023 · AI
Flow Cytometry
$540,453Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P30 · FY2011 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$540,450Gordon B. Mills · Oregon Health & Science University · U01 · FY2021 · CA
CAREER: Development of acid-cleavable linkers for drug delivery
$540,412Jerry Yang · University Of California-San Diego · · FY2009 · MPS
Integrated Translational Genoproteomics Center at Washington University
$540,405David G Mutch · Washington University · U10 · FY2017 · CA
POLYSIALIC ACID AS A MEDIATOR OF BREAST CANCER PROGRESSION AND A POTENTIAL BIOMARKER FOR RISK STRATIFICATION
$540,383The University Of British Columbia · · FY2016 · Department of the Army